MDCX - Medicus Pharma Ltd. News

Medicus Pharma And Yorkville Mutually Agree To Terminate Standby Equity Purchase Agreement For Up To

On September 11, 2026, Medicus Pharma Ltd. (the "Company") and YA II PN, LTD. ("Yorkvill

Medicus Pharma CEO on SkinJect and Pfizer partnership – ICYMI

Medicus Pharma (NASDAQ:MDCX) earlier this week outlined progress across its SkinJect program and a c

Wall Street sets positive tone as investors digest hotter inflation data

Positive tone Wall Street opened sharply higher on Friday, with the Dow Jones Industrial Average and

Medicus Pharma reports positive Phase 2 data for SkinJect in skin cancer treatment

Medicus Pharma (NASDAQ:MDCX) said a completed Phase 2 study of its SkinJect therapy showed all 90 en

Medicus Pharma Posts Phase 2 Clinical Study Report For SKNJCT‑003 On ClinicalTrials.gov, Offering Pu

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided,

Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identi

CSR provides a clinical foundation for the Company's recently announced capital-efficient focus on F

Dow falls as Treasury yields jump to highest level since 2023

10:05am: Rising yields pressure stocks Stocks moved lower at the open on Thursday as Treasury yields

Wall Street slips for a third straight day as oil and yields climb

4:20pm: Treasury yields climb Wall Street extended its selloff on Wednesday, with the Dow Jones Indu

Medicus Pharma reorients around new cancer drug candidate, sharpens focus for other programs

Medicus Pharma (NASDAQ:MDCX) is repositioning itself as a precision oncology-led biotechnology compa

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Company prioritizes CD228V precision oncology development in Melanoma while pursuing capital-efficie

Medicus Pharma Inks Global Licensing Deal with Pfizer Worth Over $1 Billion

Medicus Pharma Ltd. (NASDAQ:MDCX) secured on Wednesday an exclusive, sublicensable global license fr

Medicus Pharma Inks Global Licensing Deal with Pfizer Worth Over $1 Billion

Medicus Pharma partners with Pfizer to commercialize CD228V in a licensing deal worth over $1 billio

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Cypherpunk Technologies (NASDAQ:CYPH) shares rose 30.4% to $2.19 during Thursday's regu

Nasdaq Gains Over 200 Points; US Weekly Jobless Claims Edge Higher

U.S. stocks climbed, led by Nasdaq; communications shares rose, energy fell, while MIMI surged and R

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Gelteq (NASDAQ:GELS) shares increased by 38.6% to $0.97 during Thursday's pre-market se

Medicus Pharma advances pipeline during Q2 with key milestones

Medicus Pharma (NASDAQ:MDCX) has reported second quarter financial results and regulatory and clinic

Medicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate

Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.21) per share which missed the analyst

accessnewswire.com

Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Company Highlights Significant Regulatory, Clinical and Strategic Progress Across SkinJect® and Teve

SK Hynix backed by Wedbush as memory undersupply persists

SK Hynix Inc (NASDAQ:SKHY) has received an ‘Outperform’ rating from Wedbush on Tuesday as the firm i

proactiveinvestors.co.uk

Medicus Pharma CMO to lead Antev's Teverelix clinical programme

Medicus Pharma (NASDAQ:MDCX) announced it has put its chief medical officer in charge of UK subsidia

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdo

Dr. Mehmud's appointment further aligns the scientific, clinical, regulatory and operational leaders

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Medicus Pharma (NASDAQ:MDCX) earlier this week announced that the US Food and Drug Administration (F

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Medicus Pharma (NASDAQ:MDCX) earlier this week announced that the US Food and Drug Administration (F

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix

Medicus Pharma (NASDAQ:MDCX) announced that the United Arab Emirates Department of Health – Abu Dhab

Roblox shares plummet on revenue miss, withdrawn guidance

Roblox Corp (NYSE:RBLX) shares fell nearly 30% to around $34 following the company’s second quarter

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospecti

Randomized Phase 2a PRECISION-E2 study designed to evaluate a predefined panel of genes to advance p

EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi

Medicus Pharma obtained UAE approval for its PRECISION-E2 Phase 2a clinical trial testing Teverelix

Reddit shares slump after management warns of search traffic volatility despite strong earnings beat

Reddit Inc (NYSE:RDDT) shares fell about 21% on Friday morning after management warned of volatility

Medicus Pharma Receives FDA's Study May Proceed Letter Authorization For Its Investigational New Dru

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Frida

Medicus Pharma Announces Positive FDA Feedback For Its Optimized Phase 2 Clinical Trial Of Teverelix

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life scie

12 Health Care Stocks Moving In Thursday's Intraday Session

Medicus Pharma Files Rare Pediatric Disease Designation Request To FDA For SkinJect Microneedle Arra

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

Medicus Pharma Submits IND Application To DOH For PRECISION-E2, Phase 2a Genomics-Enabled Clinical T

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

Medicus Pharma Submits Modification Application Through European Union Clinical Trials Information S

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life scie

Medicus Pharma Submits Protocol SKNJCT-005 To FDA Under Existing IND Application, For SkinJect Into

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

Medicus Pharma Receives $22M In Non-Dilutive Financing

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate

Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.31) per share which missed the analyst

EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study

Medicus Pharma reports dose-response in Phase 2 BCC study, with 200µg cohort showing the strongest e

Medicus Pharma Highlights Results From Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis; Says

200μg Cohort Achieves 55% Complete Response at Day 57 Emerging asRegistrational Grade Lead RegimenTh

12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the compan

Medicus Pharma Files Orphan Drug Designation To FDA For SkinJect To Treat Basal Cell Carcinoma In Pa

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life scien

Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

J B Hunt Transport Services Inc (JBHT) stock rose in pre-market trading after beating earnings estim

12 Health Care Stocks Moving In Wednesday's Pre-Market Session